InsidersTradesSigma
新天药业 Stock: price and directors' dealings · China · SSE / SZSE (CSRC)
Follow the 新天药业 stock price and the full directors' dealings record of the company, a listed issuer based in China. Shares are listed on CN CN, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 新天药业 has logged 9 public disclosures. Market capitalisation: €2.4bn. The latest transaction was filed on 18 December 2025 (Sale). Among the most active insiders: 陈珏蓉. Every trade is openly available.
9
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
9 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 19,317 of 25,564 companies
34.2
score / 100
Value30
Quality38
FCF yld1.8%
Earn yld0.5%
EV/EBITDA37.1x
ROE0.7%
Gross mgn72%
Net mgn1.2%
Debt/EBITDA10.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 18 December 2025
Declarations9 total
2,190,500 sharesA股XSHESZSE:273000000052638400
9 of 9 declarations